CX11 tablets for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests an experimental drug called CX11 to see if it helps control blood sugar in people with type 2 diabetes who are already taking metformin. It may be an option for you if your blood sugar is not well controlled and you meet the health requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had type 2 diabetes for at least 6 months.
- Your average blood sugar (HbA1c) is between 7.0% and 10.5%.
- Your weight has been steady for the past 3 months.
- You are currently taking at least 1000 mg of metformin daily, with or without another diabetes medicine (SGLT2i), for at least 3 months.
- Your body mass index (BMI) is between 23 and 50.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication called CX11 is safe and well-tolerated at different doses in people with overweight or obesity. The goal is to understand how the body responds to the drug before larger trials test whether it helps with weight loss.
This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study tests how food affects the absorption of a new drug called CX11 in healthy volunteers. The results will help determine if the drug should be taken with or without food.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
This trial tests a new once-daily tablet (elecoglipron) against a placebo to see if it can help improve blood sugar control in adults with type 2 diabetes who are already on insulin. It may offer an additional treatment option to help manage your diabetes.
Hear when a new Type II Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.